Addendum
暂无分享,去创建一个
D. Armstrong | B. Yu | D. Drutz | H. Scholer | D. Nováčková
[1] J. Graybill,et al. Treatment of experimental murine aspergillosis with BAY n7133. , 1983, The Journal of infectious diseases.
[2] S. Hamilton,et al. Disseminated aspergillosis complicating hepatic failure. , 1983, Archives of Internal Medicine.
[3] A. Williams,et al. DISSEMINATED ASPERGILLOSIS IN HIGH DOSE STEROID THERAPY , 1983, The Lancet.
[4] R. Stahel,et al. Systemic fungal infections in haematological malignancies: A growing problem , 1982 .
[5] W. Lee,et al. Fungal infections in patients with acute leukemia. , 1982, The American journal of medicine.
[6] F. Rhame,et al. Aspergillus osteomyelitis. Report of four cases and review of the literature. , 1982, The American journal of medicine.
[7] A. Polak,et al. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. , 1982, Chemotherapy.
[8] D. Armstrong,et al. Invasive Aspergillosis: Progress in early diagnosis and treatment , 1981 .
[9] L. Young,et al. Aspergillosis complicating neoplastic disease. , 1973, The American journal of medicine.
[10] G. Smith,et al. Experimental aspergillosis in mice: aspects of resistance , 1972, Epidemiology and Infection.
[11] D. K. Sandhu,et al. Effect of cortisone on bronchopulmonary aspergillosis in mice exposed to spores of various Aspergillus species. , 1970, Sabouraudia.